Financial Statements — APMD
Balance Sheet
(in millions USD)| Metric | Q2
2026 |
|---|
| Cash & Equivalents | 172.80 |
| Accounts Receivable | 0.69 |
| Total Current Assets | 184.77 |
| Property, Plant & Equipment | 0.05 |
| Total Non-current Assets* | 10.68 |
| Total Assets | 195.46 |
| Accounts Payable | 6.60 |
| Total Current Liabilities | 35.58 |
| Long-term Debt | 40.27 |
| Total Non-current Liabilities* | 90.12 |
| Total Liabilities | 125.70 |
| Retained Earnings | (203.69) |
| Total Stockholder Equity | (176.18) |
* Derived from reported values
Income Statement
(in millions USD)| Metric | Q2
2026 |
|---|
| Total Revenue | 12.08 |
| Research & Development | 9.90 |
| Selling, General & Admin | 12.67 |
| Total Operating Expenses | 23.78 |
| Operating Income | (11.70) |
| Pretax Income | 126.11 |
| Tax Provision | 0.00 |
| Net Income | 125.94 |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 |
|---|
| Operating Cash Flow | (37.92) |
| Investing Cash Flow | 99.66 |
| Financing Cash Flow | 69.18 |
